PTPIPetros Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Petros Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTPIThis | $3M#1 | 0.1x#2 | 3.8x#5 | 0.5x#1 | -12.2%#1 | 113.4%#1 | -90.8%#1 | 273.0%#1 | — | — | — | — |
| MTNB | $2M#2 | — | 1.3x#4 | 2.2x#2 | -65.6%#3 | 57.3%#2 | -635.0%#2 | -574.7%#4 | — | — | — | — |
| BTAI | $2M#3 | — | — | 3.6x#3 | -71.7%#5 | -17.3%#6 | -7860.0%#5 | — | — | — | — | — |
| OGEN | $2M#4 | 0.5x#3 | 0.6x#2 | 61.1x#6 | -71.4%#4 | 6.9%#5 | -24865.2%#6 | -26814.1%#5 | — | — | — | — |
| BFRGW | $2M#5 | — | 0.3x#1 | 17.8x#5 | — | 7.1%#4 | -5652.4%#4 | -93.0%#2 | -5287.3%#1 | — | — | — |
| NXTS | $2M#6 | 0.0x#1 | 1.0x#3 | 9.1x#4 | -20.2%#2 | 22.9%#3 | -2014.3%#3 | -210.2%#3 | — | 4#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice